Point72 Asia (Singapore) Pte. Ltd. Sutro Biopharma, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $646 Billion
- Q3 2025
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 31,026 shares of STRO stock, worth $29,474. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,026
Previous 61,068
49.19%
Holding current value
$29,474
Previous $43.6 Million
38.2%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding STRO
# of Institutions
91Shares Held
57.3MCall Options Held
75KPut Options Held
0-
Black Rock Inc. New York, NY6.91MShares$6.57 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.49MShares$6.16 Million0.17% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.09MShares$4.83 Million0.38% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$4.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.68MShares$3.5 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $49.6M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...